Home › Funds › Baldwin Investment Management, LLC › ABT

Baldwin Investment Management, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Baldwin Investment Management, LLC reported holding 32,485 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$3.2M, representing 0.30% of its reported portfolio and ranking #48 among its reported holdings. Baldwin Investment Management, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)32.48K sh
Reported value held$3.21M
Portfolio Weight0.30%
First reportedQ3 2023
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Baldwin Investment Management, LLC's ABT position evolved

Baldwin Investment Management, LLC first disclosed a stake in ABT in Q3 2023 at 34,466 shares (US$3.3M). The position peaked in Q3 2025 at 39,465 shares, worth US$5.3M. Across 13 filings, Baldwin Investment Management, LLC increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 32,485 shares valued at US$3.2M — a reduction of -5,360 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 34.47K $3.34M New
Q4 2023 31.97K $3.52M Reduce
Q1 2024 33.29K $3.78M Add
Q2 2024 33.51K $3.48M Add
Q3 2024 34.16K $3.90M Add
Q4 2024 35.74K $4.04M Add
Q1 2025 37.45K $4.97M Add
Q2 2025 37.96K $5.16M Add
Q3 2025 39.47K $5.29M Add
Q4 2025 39.56K $4.96M Hold
Q1 2026 39.82K $4.09M Add
Q2 2026 37.84K $3.43M Reduce
Q3 2026 32.48K $3.21M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Baldwin Investment Management, LLC held ABT?

Baldwin Investment Management, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Baldwin Investment Management, LLC's current position in ABT?

As of Q3 2026, Baldwin Investment Management, LLC holds 32.48K shares of ABT (ABBOTT LABORATORIES), valued at $3.21M, representing 0.30% of its reported portfolio and ranking #48.

Has Baldwin Investment Management, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Baldwin Investment Management, LLC reduced its position in ABT. The position peaked in Q3 2025 at 39.47K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.